Nathan Vanalken

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Inflammatory Response

Regulatory T Cells

Top Venues

Cancer immunology, immunotherapy : CII

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Katrijn Boon, Nathan Vanalken, Eef Meyen, Dominique Schols, Tom Van Loy
REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors. Biosensors 13 (8) (2023)
Nathan Vanalken, Katrijn Boon, Jordi Doijen, Dominique Schols, Tom Van Loy
Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism. International journal of molecular sciences 23 (16) (2022)